Michelle Thom
After completing a BSc (Hons) in Applied Biological Sciences at the University of the West of England, including 12-month industrial placement at OXOID Ltd., Michelle undertook an MSc by Research in Clinical and Veterinary Medicine at the University of Bristol. Her research investigated how antigen-presenting cells respond to infection with Mycobacterium bovis.
Michelle began her research career at the Institute for Animal Health, where she developed extensive expertise in livestock immunology, vaccinology and infectious disease research. Her work focused on bovine tuberculosis (bTB), including BCG vaccine efficacy, duration of immunity, correlates of protection, diagnostic assay development and the immunological effects of tuberculin skin testing. Later, whilst working as a Visiting Research Scientist at the University of Reading, Michelle worked on a reverse-vaccinology approach to bTB using high-throughput expression to generate more than 100 full-length M. bovis proteins for cattle immunisation studies.
Michelle’s other area of focus was the development and evaluation of vaccines against bovine and human respiratory syncytial virus (RSV). Her work included evaluating stabilised prefusion RSV F proteins and investigating the importance of the prefusion conformation for inducing protective immune responses. She also contributed to studies of viral-vectored, recombinant and subunit RSV vaccines, including their safety and efficacy in calves with maternally derived antibodies. She joined The Pirbright Institute in 2017 to work on the RSV and porcine reproductive and respiratory syndrome virus (PRRSV) projects as part of the NEOVACC programme. Her RSV work included the production and evaluation of recombinant proteins and monoclonal antibodies to support vaccine development. For the PRRSV project, she engineered recombinant viruses expressing immune checkpoint inhibitors and evaluated their potential to enhance vaccine responses in piglets with maternally derived antibodies.
Michelle later joined the Immunogenetics Group, where she coordinated multidisciplinary antibody research programmes and led projects investigating B-cell biology and humoral immunity in livestock. She was promoted to Senior Research Scientist in 2025 and is now a member of the B Cell Dynamics Group. Her current research focuses on understanding how B-cell and antibody responses develop following infection and vaccination in livestock. She combines multiparameter and spectral flow cytometry, antigen-specific B-cell isolation, single-cell sorting, ELISpot, serology, molecular biology and antibody-repertoire sequencing to study protective immunity in cattle, pigs and chickens. Her research includes early B-cell development in neonatal cattle, humoral responses to M. bovis, cross-species immunity to H5N1 avian influenza, and antibody features associated with improved foot-and-mouth disease vaccine cross-reactivity. She also leads the bTB work package within the Livestock Antibody Hub programme.
Projects
Committees
- Chair, Institute External Seminar Programme
- Jenner Biological Risk User Committee
- Jenner Building Processing Committee
Conferences
- 2025: International Veterinary Immunology Symposium, Vienna, Austria.
- 2024: Pirbright Bovine Tuberculosis Workshop, The Pirbright Institute, UK.